Milestone Pharmaceuticals Inc Cash Flow Reinvestment Rate

Latest as of June 2021: 19.75x

Milestone Pharmaceuticals Inc cash flow reinvestment rate. Milestone Pharmaceuticals Inc (MIST) has a Cash Flow Reinvestment Rate of 19.75x as of June 2021, reinvesting $20.05 Million (capex $46.00K plus investments $20.00 Million) from operating cash flow of $1.01 Million. Explore MIST cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

19.75x
(Capex + Investments) / Operating CF

Total Reinvested

$20.05 Million
Capex + Investments

Operating Cash Flow

$1.01 Million
USD

Capital Expenditures

$46.00K
USD

Milestone Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (None–None)

Milestone Pharmaceuticals Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Milestone Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash flow conversion of Milestone Pharmaceuticals Inc.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow